Calibrate
Status: Reported · 3 row(s) on file · checked 2026-08-25
A data file, not a finished review: the prices below are third-party Reported figures with their source and check date. They move to First-party only after our own dated walk of Calibrate's pages — and this page will say so when they do.
Reported pricing on file · semaglutide, tirzepatide
- Listed without a rank
- On the read of 2026-09-17, Calibrate’s public pages print no rankable semaglutide, tirzepatide price — '$199/MONTH' program with an initial three-month commitment ($597 'paid in monthly installments'), then month to month; brand GLP-1s through insurance ('$25/month or less' for most commercially insured members); no compo. Nothing on this site averages, estimates or infers a price a provider did not publish; the program is listed, never ranked.
- Provenance
- joincalibrate.com · checked 2026-08-25
Provider scorecard — the fields the sprint fills
| Pharmacy on file | not yet on file — queued |
| Pharmacy type | queued |
| States served | 50 states + DC (verified 2026-08-25) |
| Membership · consult fee | queued · queued |
| Dose-change policy | queued |
| Cancellation terms | queued |
| Shipping | queued |
| Intro price (first month/period) | — |
| Medication included in price | no |
| Offer conditions on file | program ≈$199/mo, medication and labs excluded; brand out-of-pocket varies by insurance/savings eligibility |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-08-25 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- Read 2026-09-17: '$199/MONTH' program with an initial three-month commitment ($597 'paid in monthly installments'), then month to month; brand GLP-1s through insurance ('$25/month or less' for most commercially insured members); no compounded medication and no cash medication price printed.
- Read 2026-09-17: '$199/MONTH' program with an initial three-month commitment ($597), then month to month; brand Mounjaro/Zepbound through insurance; no compounded tirzepatide and no cash medication price printed.
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, Calibrate appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
No outbound link: we have not confirmed this program's canonical domain first-party, and we do not guess URLs.